Brachytherapy: Market Research Report

Date: January 4, 2014
Pages: 166
Price:
US$ 4,500.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B564A0C4345EN
Leaflet:

Download PDF Leaflet

Brachytherapy: Market Research Report
This report analyzes the worldwide markets for Brachytherapy in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 36 companies including many key and niche players such as -
  • Best Medical International, Inc.
  • Boston Scientific Corporation
  • COOK Medical, Inc.
  • C. R. Bard, Inc.
  • Gammex, Inc.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting LimitationsDisclaimersData Interpretation & Reporting LevelQuantitative Techniques & AnalyticsProduct Definition and Scope of Study
II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW I
Brachytherapy - A Prelude IThe US Leads the Brachytherapy Devices Market Developing Regions to Spearhead Growth IBrachytherapy Provides More Hope for Cancer Patients Compared to EBRT IComparison of Brachytherapy Over EBRT in Prostate Cancer Treatment IGrowing Cancer Cases in Developing Countries Bodes Well for the Brachytherapy Market IRecent Technological Advancements Show Promising Future for the Brachytherapy Market I
2. MAJOR MARKET DRIVERS, TRENDS & ISSUES I
Increase in Diagnosed Cases of Cancer – A Major Growth Driver I
Table 1. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart) I
Table 2. New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart) I
Table 3. Cancer Incidence in Developed Nations By Site: 2012 (includes corresponding Graph/Chart) I
Table 4. Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart) I
Table 5. Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart) I
Table 6. World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart) I
Table 7. Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal, and Prostate Cancers (includes corresponding Graph/Chart) I
Table 8. Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal, and Liver Cancers (includes corresponding Graph/Chart) II-1

Cancer Prone Sites based on Age II-1Ballooning Global Population Offers Significant Growth Opportunities II-1
Table 9. Top 25 Countries Worldwide in Terms of Population: 2010 & 2013 II-1

Rising Healthcare Needs of Aging Global Population Drives Brachytherapy II-1
Table 10. Life Expectancy Rates at Birth by Geographic Region: 1990 & 2011 (includes corresponding Graph/Chart) II-1
Table 11. Global Population Statistics for the 65+ Age Group (2012) (includes corresponding Graph/Chart) II-1
Table 12. Percentage of Population Aged 65 and Above in Europe, US, and Japan (1960-2030) (includes corresponding Graph/Chart) II-1
Table 13. Elderly Population (65+ Years) as a Percentage of the Total Population: 2025 (includes corresponding Graph/Chart) II-1

Prostate Brachytherapy Offers Bright Prospects II-1Reimbursement Scenario – A Major Issue II-1Competition Heats Up in the Brachytherapy Market II-1
Table 14. Global Brachytherapy Devices Market by Leading Players (2012): Percentage Market Share Breakdown of Value Sales for Nucletron, Oncura, CR Brad, Varian, Theragenics, Eckert and Ziegler BEBIG, and Others (includes corresponding Graph/Chart) II-1

Macular Degeneration – An Emerging Brachytherapy Application II-1APBI Therapy Rise in Popularity II-1Balloon Brachytherapy Gains Prominence II-1Radiation Safety – An Important Issue in Brachytherapy Treatment II-1
3. RESEARCH & STUDY FINDINGS II-1
Brachytherapy – Highly Benefitting Young Prostate Cancer Patients II-1Research Reveals Lower Rate of Breast Preservation in Older Women undergoing Brachytherapy Treatment II-1Possibility of Hematuria, Up to Several Years after Brachytherapy Treatment Completion II-1Researchers at Duke University Develops a Biodegradable Brachytherapy Treatment II-1Study Finds Increased Risk of Complications after Breast Brachytherapy II-1Another Study Reveals Increased Risk of Re-occurrence of Breast Cancer Using Brachytherapy II-1Brachytherapy Found to be Useful in Treating High-Risk Prostate Cancer Cases as well II-1Brachytherapy - The Effective One among the Three Prostate Cancer Treatment II-2Brachytherapy – Cost Effective for Prostate Cancer Treatment Compared to IMRT II-2
4. PROSTATE CANCER – A MAJOR BRACHYTHERAPY INDICATION II-2
Prostate Cancer – A Deadly Disease II-2Brachytherapy Revolutionizes Prostate Cancer Treatment II-2Side Effects Do Exist II-2Seed Migration – A Cause of Concern? II-2History Behind the Development II-2Prostate Brachytherapy Procedure II-2Seed Brachytherapy Clinical Outcomes II-2Types of Brachytherapy Procedures for Prostate Cancer Treatment II-2Interstitial brachytherapy II-2Combination Radiotherapy II-2Whole Pelvic Radiation Therapy II-2
5. OTHER MAJOR BRACHYTHERAPY INDICATIONS II-2
Breast Cancer II-2Breast Brachytherapy – An Introduction II-2How is Breast Brachytherapy Performed? II-2Breast Brachytherapy Techniques II-2Brain Brachytherapy II-2Brain Tumor II-2Types of Brain Tumor II-2Treatment Techniques II-2Brain Brachytherapy II-2Whole Brain Radiation Therapy II-2Bronchial Carcinoma II-2Bronchial Brachytherapy II-2Procedure II-2Head and Neck Brachytherapy II-3Cervical Brachytherapy II-3Esophageal Brachytherapy II-3Brachytherapy for Eyelid Tumors II-3Other Indications II-3
6. PRODUCT OVERVIEW II-3
What is Brachytherapy? II-3Implantable Prostate Seeds Brachytherapy II-3Post-Operative Brachytherapy II-3Mechanism of Action II-3Brachytherapy – Under the Microscope II-3Brachytherapy Sources II-3The Team II-3A Historical Perspective II-3Brachytherapy – A Classification II-3Types as Per Seed Positioning II-3Mold Brachytherapy II-3Interstitial Brachytherapy II-3Endovascular Brachytherapy II-3Stent-Based Techniques II-3Catheter-Based Techniques II-3Intracavitary Brachytherapy II-3Classification as per Irradiation Duration II-3Temporary Brachytherapy II-3Permanent Brachytherapy II-3Categorization as per the Dose Rate II-3HDR Brachytherapy II-3LDR Brachytherapy II-3PDR Brachytherapy II-3PDR Brachytherapy Vs. HDR Brachytherapy II-3PDR Brachytherapy Vs. LDR Brachytherapy II-3
7. BRACHYTHERAPY EQUIPMENT II-3
Brachytherapy Systems II-3Remote Afterloading Machines II-3Manual Afterloading Machines II-3Brachytherapy Applicators II-4Types of Brachytherapy Applicators II-4Automated Brachytherapy Applicators II-4Manual Brachytherapy Applicators II-4
8. RECENT INDUSTRY ACTIVITY II-4
IsoRay Obtains CE Mark Extension for Cesium-131 seeds Products Range II-4AMIC to Pursue Regulatory Down-Classification of Brachytherapy Cancer Product II-4Elekta Receives FDA Approval for Esteya Electronic Brachytherapy II-4Advanced Medical Isotope Corporation Submits 510(k) Pre-Market Notification of Yttrium-90 RadioGel Brachytherapy II-4Cianna Medical Obtains Approval for SAVI Breast Brachytherapy in Japan II-4Accelyon Enters into a Supply Agreement with AnazaoHealth Corporation II-4Civco Obtains FDA Approval for Ultrasound-guided Brachytherapy II-4Nucletron Launches Esteya II-4Nucletron, an Elekta company Receives CE marking for Esteya II-4Theragenics Signs Agreement with Accelyon II-4BTG Divests Brachytherapy Business to Eckert & Ziegler II-4iCAD Receives FDA Clearance of Cervical Applicator for Xoft Electronic Brachytherapy System II-4iCAD Enters into Distribution Agreements of Xoft Axxent Electronic Brachytherapy System in Russia and Asia II-4Theragenics Receives Patent for Expandable Brachytherapy Device II-4Elysian Capital Acquires Accelyon Limited II-4Eckert & Ziegler BEBIG Acquires MRNI II-4Theragenics Enters into Agreement with Oncura II-4Nucletron Receives Approval for Digital Brachytherapy Afterloader in Japan II-4Varian Medical Systems Rolls Out Latest Version of Vitesse II-4
9. FOCUS ON SELECT PLAYERS II-4
Best Medical International, Inc. (US) II-4Best Vascular, Inc. (US) II-4Boston Scientific Corporation (US) II-4COOK Medical, Inc. (US) II-4C. R. Bard, Inc. (US) II-4Eckert & Ziegler Strahlen & Medizintechnik AG (Germany) II-4Gammex, Inc. (US) II-4Nucletron BV (Netherlands) II-4Oncura, Inc. (US) II-4Sirtex Medical Limited (Australia) II-4Theragenics Corporation (US) II-4Varian Medical Systems, Inc. (US) II-4Xoft, Inc. (US) II-4
10. GLOBAL MARKET PERSPECTIVE II-4

Table 15. World Recent Past, Current & Future Analysis for Brachytherapy Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) II-4
Table 16. World Historic Review for Brachytherapy Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) II-5
Table 17. World 15-Year Perspective for Brachytherapy Devices by Geographical Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) II-5

III. MARKET

1. THE UNITED STATES II
A. Market Analysis IICancer Presumes Epidemic Proportion II
Table 18. New Cancer Cases by Gender and Affected Site in the US (2013) II

Growing Cancer Prevalence Drives Brachytherapy Demand IIBrachytherapy – Effective Option for Cancer Treatment IIRapid Growth in Prostate Brachytherapy Market IITechnology Advancements Accelerate Growth IIBreast Brachytherapy Witnesses Slow Growth IIBrachytherapy Treatment for Cervical Cancer Declines, Despite High Survival Rates IIBalloon Brachytherapy Makes Inroads into the Mainstream Market IIReimbursement Scenario IIGrowth Drivers IIOngoing Research Activities Drive Acceptance of Brachytherapy IIInflux of New Players Drives Growth IINew Developments Propel Market Growth IIStrategic Corporate Developments IIFocus on Select Players IIB. Market Analytics III-1
Table 19. The US Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed With Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-1
Table 20. The US Historic Review for Brachytherapy Devices Market Analyzed With Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-1

2. CANADA III-1
Market Analysis III-1
Table 21. Canadian Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed With Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-1
Table 22. Canadian Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-1

3. JAPAN III-1
A. Market Analysis III-1Strategic Corporate Developments III-1B. Market Analytics III-1
Table 23. Japanese Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed With Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-1
Table 24. Japanese Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-1

4. EUROPE III-1
A. Market Analysis III-1Debt Crisis in Europe Affects Healthcare Industry III-1European Healthcare System: In a State of Transition? III-1Cancer Trends III-1
Table 25. Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart) III-2

Brachytherapy in Europe III-2Aging Population to Drive Demand for Brachytherapy III-2
Table 26. Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart) III-2

New EU Law to Drive Demand for Brachytherapy Devices III-2Prostate Brachytherapy Gains Strength III-2Competitive Analysis III-2Strategic Corporate Developments III-2B. Market Analytics III-2
Table 27. European Recent Past, Current & Future Analysis for Brachytherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-2
Table 28. European Historic Review for Brachytherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-2
Table 29. European 15-Year Perspective for Brachytherapy Devices by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-2

4A. FRANCE III-2
A. Market Analysis III-2A Focus on the Prostate Brachytherapy Market III-2B. Market Analytics III-2
Table 30. French Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-2
Table 31. French Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-2

4B. GERMANY III-2
A. Market Analysis III-2Strategic Corporate Developments III-2Eckert & Ziegler Strahlen & Medizintechnik AG – A Key Player III-2B. Market Analytics III-3
Table 32. German Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-3
Table 33. German Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-3

4C. ITALY III-3
Market Analysis III-3
Table 34. Italian Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-3
Table 35. Italian Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-3

4D. UNITED KINGDOM III-3
A. Market Analysis III-3UK Prostate Brachytherapy Market – An Overview III-3Strategic Corporate Development III-3B. Market Analytics III-3
Table 36. The UK Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-3
Table 37. The UK Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-3

4E. SPAIN III-3
Market Analysis III-3
Table 38. Spanish Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-3
Table 39. Spanish Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-3

4F. RUSSIA III-3
Market Analysis III-3
Table 40. Russian Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-3
Table 41. Russian Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-4

4G. REST OF EUROPE III-4
A. Market Analysis III-4Strategic Corporate Developments III-4Nucletron BV (Netherlands) – Select Player III-4B. Market Analytics III-4
Table 42. Rest of Europe Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-4
Table 43. Rest of Europe Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-4

5. ASIA-PACIFIC III-4
A. Market Analysis III-4Growing Medical Tourism in Asia-Pacific Bodes Well for the Brachytherapy Market III-4Sirtex Medical Limited (Australia) – A Review III-4B. Market Analytics III-4
Table 44. Asia-Pacific Recent Past, Current & Future Analysis for Brachytherapy Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-4
Table 45. Asia-Pacific Historic Review for Brachytherapy Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-4
Table 46. Asia-Pacific 15-Year Perspective for Brachytherapy Devices by Geographic Region - Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-4

6. THE MIDDLE EAST III-4
Market Analysis III-4
Table 47. The Middle East Recent Past, Current & Future Analysis for Brachytherapy Devices Market Analyzed With Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-4
Table 48. The Middle East Historic Review for Brachytherapy Devices Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-4

7. LATIN AMERICA III-5
Market Analysis III-5
Table 49. Latin American Recent Past, Current & Future Analysis for Brachytherapy Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart) III-5
Table 50. Latin American Historic Review for Brachytherapy Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart) III-5
Table 51. Latin American 15-Year Perspective for Brachytherapy Devices by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-5

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 36 (including Divisions/Subsidiaries - 41)The United States (26)Canada (1)Europe (12)  Germany (4)  The United Kingdom (2)  Rest of Europe (6)Asia-Pacific (Excluding Japan) (2)
Skip to top


Ask Your Question

Brachytherapy: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: